Europe Pulmonary Function Testing Systems Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Cart-Based PFT Systems and Stationery PFT Systems), Test Type (Spirometry, Lung Volume, Gas Exchange Testing, Maximum Voluntary Ventilation, Oxygen Titration Test, and Others), Component (Hardware, Software, and Services), Application (Chronic Obstructive Pulmonary Disorder, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, and Others), and End User (Hospitals, Specialty Clinics, and Diagnostic Laboratories)
The Europe pulmonary function testing systems market was valued at US$ 77.72 million in 2022 and is expected to reach US$ 112.11 million by 2028; it is estimated to register a CAGR of 6.3% from 2022 to 2028.
Incidences of Occupational Lung Diseases Fuels Europe Pulmonary Function Testing Systems Market
Rising incidences of occupational lung disease are among the most influential factors accelerating the demand for pulmonary function testing systems. A pulmonary function testing system helps determine occupational lung disease among workers. As spirometry testing is intended for both screening and clinical evaluations at the workplace, it is performed in small clinical practices, small-sized industries, and multiple plant medical departments within an industry. Such an effective practice at the workplace has significant demand for pulmonary function testing systems.
Europe Pulmonary Function Testing Systems Market Overview
The Europe pulmonary function testing systems market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The market growth is attributed to the surging number of patients suffering from COPD and asthma and the growing number of visits to independent physician clinics to diagnose these diseases. Also, improvements in healthcare infrastructure and the presence of major market players in the region are a few factors increasing the demand for PFT systems in Europe.
Europe Pulmonary Function Testing Systems Market Revenue and Forecast to 2028 (US$ Million)
Europe Pulmonary Function Testing Systems Market Segmentation
The Europe pulmonary function testing systems market is segmented on the basis of type, test type, component, application, end user, and country.
Based on type, the Europe pulmonary function testing systems market is bifurcated into cart-based PFT systems and stationery PFT systems. The cart-based PFT systems segment held a larger share of the Europe pulmonary function testing systems market in 2022.
Based on test type, the Europe pulmonary function testing systems market is segmented into spirometry, lung volume, gas exchange testing, maximum voluntary ventilation, oxygen titration test, and others. The spirometry segment held the largest share of the Europe pulmonary function testing systems market in 2022.
Based on component, the Europe pulmonary function testing systems market is segmented into hardware, software, and services. The hardware segment held the largest share of the Europe pulmonary function testing systems market in 2022.
Based on application, the Europe pulmonary function testing systems market is segmented into chronic obstructive pulmonary disorder, asthma, chronic shortness of breath, restrictive lung disease, and others. The chronic obstructive pulmonary disorder segment held the largest share of the Europe pulmonary function testing systems market in 2022.
Based on end-user, the Europe pulmonary function testing systems market is segmented into hospitals, specialty clinics, and diagnostic laboratories. The hospitals segment held the largest share of the Europe pulmonary function testing systems market in 2022.
Based on country, the Europe pulmonary function testing systems market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the share of the Europe pulmonary function testing systems market in 2022.
COSMED Srl, KoKo PFT Ltd, MGC Diagnostics Corp, ndd Medical Technologies Inc, PulmOne Advanced Medical Devices Ltd, Schiller AG, and Vyaire Medical Inc are the leading companies operating in the Europe pulmonary function testing systems market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Pulmonary Function Testing Systems Market – By Type
1.3.2 Europe Pulmonary Function Testing Systems Market – By Test Type
1.3.3 Europe Pulmonary Function Testing Systems Market – By Component
1.3.4 Europe Pulmonary Function Testing Systems Market – By Application
1.3.5 Europe Pulmonary Function Testing Systems Market – By End User
1.3.6 Europe Pulmonary Function Testing Systems Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Pulmonary Function Testing Systems Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts’ Opinion
5. Europe Pulmonary Function Testing Systems Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Lung-Related Disorders
5.1.2 Occupational Lung Diseases
5.2 Market Restraints
5.2.1 Risk of Cross-Contamination and Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Home Healthcare Pulmonary Function Testing Systems
5.4 Future Trends
5.4.1 Technological Advancements in Pulmonary Function Testing Systems
5.5 Impact Analysis
6. Pulmonary Function Testing Systems Market–Europe Analysis
6.1 Europe Pulmonary Function Testing Systems Market Revenue Forecast and Analysis
7. Europe Pulmonary Function Testing Systems Market Analysis – By Type
7.1 Overview
7.2 Europe Pulmonary Function Testing Systems Market, By Type, 2021 & 2028 (%)
7.3 Cart-Based PFT Systems
7.3.1 Overview
7.3.2 Cart-Based PFT Systems: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Stationary PFT Systems
7.4.1 Overview
7.4.2 Stationary PFT Systems: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8. Europe Pulmonary Function Testing Systems Market Analysis – By Test Type
8.1 Overview
8.2 Europe Pulmonary Function Testing Systems Market, By Test Type, 2021 & 2028 (%)
8.3 Spirometry
8.3.1 Overview
8.3.2 Spirometry: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Lung Volume
8.4.1 Overview
8.4.2 Lung Volume: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Gas Exchange Testing
8.5.1 Overview
8.5.2 Gas Exchange Testing: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Maximal Voluntary Ventilation
8.6.1 Overview
8.6.2 Maximal Voluntary Ventilation: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.7 Oxygen Titration Test
8.7.1 Overview
8.7.2 Oxygen Titration Test: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.8 Others Test
8.8.1 Overview
8.8.2 Others: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9. Europe Pulmonary Function Testing Systems Market Analysis – By Component
9.1 Overview
9.2 Europe Pulmonary Function Testing Systems Market, By Component, 2021 & 2028 (%)
9.3 Hardware
9.3.1 Overview
9.3.2 Hardware: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9.4 Software
9.4.1 Overview
9.4.2 Software: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9.5 Services
9.5.1 Overview
9.5.2 Services: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10. Europe Pulmonary Function Testing Systems Market Analysis – By Application
10.1 Overview
10.2 Europe Pulmonary Function Testing Systems Market, By Application, 2021 & 2028 (%)
10.3 Chronic Obstructive Pulmonary Disease
10.3.1 Overview
10.3.2 Chronic Obstructive Pulmonary Disease: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.4 Asthma
10.4.1 Overview
10.4.2 Asthma: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.5 Chronic Shortness of Breath
10.5.1 Overview
10.5.2 Chronic Shortness of Breath: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.6 Restrictive Lung Disease
10.6.1 Overview
10.6.2 Restrictive Lung Disease: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11. Europe Pulmonary Function Testing Systems Market Analysis – By End-User
11.1 Overview
11.2 Europe Pulmonary Function Testing Systems Market, By End-User, 2021 & 2028 (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11.4 Specialty Clinics
11.4.1 Overview
11.4.2 Specialty Clinics: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11.5 Diagnostic Laboratories
11.5.1 Overview
11.5.2 Diagnostic Laboratories: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
12. Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 – Country Analysis
12.1 Europe
12.1.1 Europe Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
12.1.1.1 Germany: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.1 Overview
12.1.1.1.2 Germany: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.3 Germany: Europe Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.1.1.4 Germany: Europe Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.1.1.5 Germany: Europe Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.1.1.6 Germany: Europe Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.1.1.7 Germany: Europe Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.1.2 UK: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.1 Overview
12.1.1.2.2 UK: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.3 UK: Europe Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.1.2.4 UK: Europe Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.1.2.5 UK: Europe Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.1.2.6 UK: Europe Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.1.2.7 UK: Europe Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.1.3 France: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.1 Overview
12.1.1.3.2 France: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.3 France: Europe Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.1.3.4 France: Europe Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.1.3.5 France: Europe Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.1.3.6 France: Europe Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.1.3.7 France: Europe Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.1.4 Italy: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.4.1 Overview
12.1.1.4.2 Italy: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.4.3 Italy: Europe Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.1.4.4 Italy: Europe Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.1.4.5 Italy: Europe Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.1.4.6 Italy: Europe Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.1.4.7 Italy: Europe Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.1.5 Spain: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.5.1 Overview
12.1.1.5.2 Spain: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.5.3 Spain: Europe Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.1.5.4 Spain: Europe Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.1.5.5 Spain: Europe Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.1.5.6 Spain: Europe Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.1.5.7 Spain: Europe Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.1.6 Rest of Europe: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.6.1 Overview
12.1.1.6.2 Rest of Europe: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.6.3 Rest of Europe: Europe Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.1.6.4 Italy: Europe Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.1.6.5 Italy: Europe Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.1.6.6 Italy: Europe Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.1.6.7 Italy: Europe Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
13. Europe Pulmonary Function Testing Systems Market – Industry Landscape
13.1 Overview
13.2 Growth Strategies in Europe Pulmonary Function Testing Systems Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 COSMED Srl
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 MGC Diagnostics Corp
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Schiller AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Vyaire Medical Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 ndd Medical Technologies Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 PulmOne Advanced Medical Devices Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 KoKo PFT Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Europe Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Europe Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Europe Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Europe Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. UK: Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK: Europe Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK: Europe Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK: Europe Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK: Europe Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Europe Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. France: Europe Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 14. France: Europe Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. France: Europe Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Italy: Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Europe Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Europe Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy: Europe Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy: Europe Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Spain: Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Spain: Europe Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Spain: Europe Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 24. Spain: Europe Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Spain: Europe Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Europe: Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Europe Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy: Europe Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 29. Italy: Europe Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 30. Italy: Europe Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Recent Organic Growth Strategies in Europe Pulmonary Function Testing Systems Market
Table 32. Recent Inorganic Growth Strategies in the Europe Pulmonary Function Testing Systems Market
Table 33. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Pulmonary Function Testing Systems Market Segmentation
Figure 2. Europe Pulmonary Function Testing Systems Market, By Country
Figure 3. Europe Pulmonary Function Testing Systems Market Overview
Figure 4. Cart-Based PFT System Segment Held Largest Share of Type Segment in Europe Pulmonary Function Testing Systems Market
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. Europe: PEST Analysis
Figure 8. Experts’ Opinion
Figure 9. Europe Pulmonary Function Testing Systems Market: Impact Analysis of Drivers and Restraints
Figure 10. Europe Pulmonary Function Testing Systems Market– Revenue Forecast and Analysis – 2020- 2028
Figure 11. Europe Pulmonary Function Testing Systems Market, by Type, 2021 & 2028 (%)
Figure 12. Cart-Based PFT Systems: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Stationary PFT Systems: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Europe Pulmonary Function Testing Systems Market, by Test Type, 2021 & 2028 (%)
Figure 15. Spirometry: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Lung Volume: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Gas Exchange Testing: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Maximal Voluntary Ventilation: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Oxygen Titration Test: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Others: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Europe Pulmonary Function Testing Systems Market, by Component, 2021 & 2028 (%)
Figure 22. Hardware: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Software: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Services: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Europe Pulmonary Function Testing Systems Market, by Application, 2021 & 2028 (%)
Figure 26. Chronic Obstructive Pulmonary Disease: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Asthma: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Chronic Shortness of Breath: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Restrictive Lung Disease: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Others: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Europe Pulmonary Function Testing Systems Market, by End-User, 2021 & 2028 (%)
Figure 32. Hospitals: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Specialty Clinics: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Diagnostic Laboratories: Europe Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Europe Pulmonary Function Testing Systems Market, by Key Country – Revenue (2021) (US$ Million)
Figure 36. Europe Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
Figure 37. Germany: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. UK: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. France: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Italy: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Spain: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Rest of Europe: Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Growth Strategies in Europe Pulmonary Function Testing Systems Market
- COSMED Srl
- KoKo PFT Ltd
- MGC Diagnostics Corp
- ndd Medical Technologies Inc
- PulmOne Advanced Medical Devices Ltd
- Schiller AG
- Vyaire Medical Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe pulmonary function testing systems market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe pulmonary function testing systems market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.